Nuubo — Series B (estimated) · €721K · partial: only one investor's ticket was disclosed

CDTI, through Innvierte, and Nuubo Investments FCRE (managed by CRB Health Tech, formerly CRB Inverbio) agreed a new capital injection in Nuubo, with CDTI committing €721K. Nuubo Investments led the round, whose total was not disclosed. The stage is inferred as a follow-on to the 2022 round.

LeadNuubo Investments FCRE RoundSeries B (estimated) Announced30 May 2024 CityMadrid SectorHealthtech & Bio · Healthtech / Medical devices Source C

Something wrong? Suggest a correction →